Codice QR

APN Inhibitor Bestatin Induces MM Cell Differentiation Through the CD79B/BTK/STAT3 Pathway

Differentiation therapy holds significant potential for the treatment of multiple myeloma (MM). We previously identified that the aminopeptidase N (APN) inhibitor Bestatin promotes MM cell differentiation. Herein, we elucidate the underlying molecular mechanisms of this process. Utilizing MM1.S, U26...

Descrizione completa

Salvato in:
Autori principali: Xiaoke Wang, Chunyan Fang, Shanyu Li, Huakai Zeng, Junyi Liu, Xinwei Duan, Xiaoyi Zhang, Wenyan Jiang, Xuejian Wang
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2026-05-01
Serie:Cells
Soggetti:
multiple myeloma
differentiation
Bestatin
CD79B/BTK
Accesso online:https://www.mdpi.com/2073-4409/15/10/949
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi